SD BioSensor, Inc
KRX:137310.KS
9330 (KRW) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) KRW.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 694,573.795 | 655,676.513 | 2,932,001.44 | 2,929,960.84 | 1,686,163.033 | 72,962.238 | 65,633.389 |
| Cost of Revenue
| 355,188.211 | 533,227.057 | 1,539,006.778 | 1,359,930.199 | 828,000.792 | 52,152.114 | 45,595.639 |
| Gross Profit
| 339,385.585 | 122,449.456 | 1,392,994.662 | 1,570,030.641 | 858,162.241 | 20,810.124 | 20,037.75 |
| Gross Profit Ratio
| 0.489 | 0.187 | 0.475 | 0.536 | 0.509 | 0.285 | 0.305 |
| Reseach & Development Expenses
| 87,945.537 | 64,202.693 | 45,762.481 | 18,885.658 | 10,387.58 | 4,869.391 | 4,265.918 |
| General & Administrative Expenses
| 23,721.024 | 22,955.324 | 12,608.286 | 4,707.117 | 1,947.12 | 1,632.233 | 0 |
| Selling & Marketing Expenses
| 60,675.859 | 88,121.909 | 75,686.791 | 123,982.968 | 79,979.015 | 4,540.288 | 0 |
| SG&A
| 84,396.883 | 111,077.233 | 88,295.077 | 128,690.085 | 81,926.135 | 6,172.521 | 12,456.537 |
| Other Expenses
| 221,100.51 | 198,806.961 | 112,312.708 | 58,414.319 | 27,584.027 | 8,248.509 | -275.543 |
| Operating Expenses
| 393,442.93 | 374,086.887 | 246,370.266 | 205,990.062 | 119,897.742 | 19,290.421 | 16,997.998 |
| Operating Income
| -54,057.346 | -248,084.57 | 1,146,624.395 | 1,364,040.579 | 738,264.499 | 1,519.703 | 3,039.753 |
| Operating Income Ratio
| -0.078 | -0.378 | 0.391 | 0.466 | 0.438 | 0.021 | 0.046 |
| Total Other Income Expenses Net
| -165,123.751 | -190,529.407 | 95,464.075 | 76,776.516 | -21,027.353 | -374.29 | 783.153 |
| Income Before Tax
| -219,181.097 | -438,613.976 | 1,242,088.47 | 1,440,817.095 | 717,237.147 | 2,202.457 | 3,822.906 |
| Income Before Tax Ratio
| -0.316 | -0.669 | 0.424 | 0.492 | 0.425 | 0.03 | 0.058 |
| Income Tax Expense
| -121,041.419 | 29,290.121 | 333,299.788 | 376,384.935 | 95,623.288 | -928.644 | -142.106 |
| Net Income
| -98,410.898 | -467,711.537 | 911,362.364 | 1,088,470.714 | 615,635.989 | 3,153.182 | 3,031.674 |
| Net Income Ratio
| -0.142 | -0.713 | 0.311 | 0.371 | 0.365 | 0.043 | 0.046 |
| EPS
| -804.63 | -4,218.95 | 8,996.76 | 11,161 | 5,990.92 | 30.68 | 29.5 |
| EPS Diluted
| -804.63 | -4,218.95 | 8,996.76 | 11,161 | 5,990.92 | 30.68 | 29.5 |
| EBITDA
| -5,366.348 | -250,858.327 | 1,187,444.296 | 1,406,847.546 | 746,238.705 | 5,850.314 | 8,463.243 |
| EBITDA Ratio
| -0.008 | -0.383 | 0.405 | 0.48 | 0.443 | 0.08 | 0.129 |